Charles Schwab Investment Management Inc Terns Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 224,220 shares of TERN stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
224,220
Previous 206,450
8.61%
Holding current value
$1.82 Million
Previous $569,000
46.92%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TERN
# of Institutions
132Shares Held
84.2MCall Options Held
173KPut Options Held
89.5K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$66.2 Million2.36% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$61.3 Million1.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.5MShares$60.8 Million0.99% of portfolio
-
Morgan Stanley New York, NY7.25MShares$58.8 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$55.9 Million5.45% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $305M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...